DK0379308T3 - Fremgangsmåde til selektivt at blokere 5HT2 receptorer - Google Patents

Fremgangsmåde til selektivt at blokere 5HT2 receptorer

Info

Publication number
DK0379308T3
DK0379308T3 DK90300325.9T DK90300325T DK0379308T3 DK 0379308 T3 DK0379308 T3 DK 0379308T3 DK 90300325 T DK90300325 T DK 90300325T DK 0379308 T3 DK0379308 T3 DK 0379308T3
Authority
DK
Denmark
Prior art keywords
receptors
selectively blocking
blocking
selectively
isopropyldihydrolysergic
Prior art date
Application number
DK90300325.9T
Other languages
English (en)
Inventor
Marlene Lois Cohen
Mark Jay Goldberg
Louis Lemberger
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0379308T3 publication Critical patent/DK0379308T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
DK90300325.9T 1989-01-17 1990-01-11 Fremgangsmåde til selektivt at blokere 5HT2 receptorer DK0379308T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/297,208 US4914107A (en) 1989-01-17 1989-01-17 Method for selectively blocking 5-HT2 receptors

Publications (1)

Publication Number Publication Date
DK0379308T3 true DK0379308T3 (da) 1992-09-28

Family

ID=23145320

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90300325.9T DK0379308T3 (da) 1989-01-17 1990-01-11 Fremgangsmåde til selektivt at blokere 5HT2 receptorer

Country Status (9)

Country Link
US (1) US4914107A (da)
EP (1) EP0379308B1 (da)
JP (1) JPH02233680A (da)
AT (1) ATE79539T1 (da)
CA (1) CA2007472A1 (da)
DE (1) DE69000259T2 (da)
DK (1) DK0379308T3 (da)
ES (1) ES2044422T3 (da)
GR (1) GR3005963T3 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE212860T1 (de) * 1994-09-19 2002-02-15 Fujisawa Pharmaceutical Co Eine neuartige medizinische verwendung eines 5ht 3-antagonisten
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB933082A (en) * 1960-10-06 1963-08-08 Sandoz Ag Improvements in or relating to lysergic acid derivatives
US3580916A (en) * 1969-02-20 1971-05-25 Lilly Co Eli Hydroxyesters of hexa- and octahydroindoloquinolines
SE396753B (sv) * 1970-05-18 1977-10-03 Richter Gedeon Vegyeszet Analogiforfarande for framstellning av en forening tillhorande dihydrolysergsyraserien
DE2330912C3 (de) * 1972-06-22 1979-01-11 Societa Farmaceutici Italia S.P.A., Mailand (Italien) Verfahren zur Herstellung von Bromergolinverbindungen
DE3207775A1 (de) * 1981-03-13 1982-09-23 Sandoz-Patent-GmbH, 7850 Lörrach Verfahren zur herstellung von mutterkornalkaloiden
US4713384A (en) * 1985-10-01 1987-12-15 Eli Lilly And Company Selective method for blocking 5HT2 receptors
US4714704A (en) * 1985-10-01 1987-12-22 Eli Lilly And Company Alkoxy cycloalkanol esters of dihydrolysergic acid useful as 5HT receptor antagonists
US4734501A (en) * 1985-10-01 1988-03-29 Eli Lilly And Company N-alkylation of dihydrolysergic acid

Also Published As

Publication number Publication date
ES2044422T3 (es) 1994-01-01
JPH02233680A (ja) 1990-09-17
GR3005963T3 (da) 1993-06-07
US4914107A (en) 1990-04-03
ATE79539T1 (de) 1992-09-15
EP0379308B1 (en) 1992-08-19
DE69000259T2 (de) 1993-03-11
CA2007472A1 (en) 1990-07-17
EP0379308A1 (en) 1990-07-25
DE69000259D1 (de) 1992-09-24

Similar Documents

Publication Publication Date Title
DK0640592T3 (da) N-acylerede tricycliske azaheteroringe anvendelige som vasopressin-antagonister
IS3398A7 (is) Aðferð við að framleiða lyfjablöndu er stýrir losun díhýdrópýridíns og beta-adrenoviðtaka antagónista
FR2624724B1 (fr) Ligament synthetique pour genou
PT94181A (pt) Processo para a preparacao de heterociclos com 6 membros imidazo-condensados substituidos uteis como antagonistas de angiotensina ii
DK0393838T3 (da) Dopaminreceptorligander og imagografimidler
ATE354364T1 (de) Verwendung von at-1 rezeptorantagonisten oder at- 2 rezeptormodulatoren zur behandlung von erkrankungen, die mit einer erhöhung an at-1 oder at-2 rezeptoren verbunden sind
FI921345A (fi) Piperidinderivat
IT8419995A0 (it) Procedimento selettivo per il blocco di ricettori di 5ht2.
DE58906034D1 (de) Vorrichtung zum Verbinden von Führungsschienen.
DE69332835D1 (de) Zusammensetzung zum desensibilisieren von zähnen
KR900011466A (ko) 고상 투여형용 안정화계
DK0379308T3 (da) Fremgangsmåde til selektivt at blokere 5HT2 receptorer
IT9086204A0 (it) Metodo per la cura dell'impotenza erettiva maschile
ZA916918B (en) Amino acid analogs as CCK antagonists.
NO895237D0 (no) Sementeringshode for oljebroenner.
IT8448082A0 (it) Composto farmaceutico a base di dii droergotossina per il trattamento dell'ipertensione
IT8719009A0 (it) Composti antagonisti di recettori -h2 e procedimento per la loro preparazione.
IT8124627A0 (it) Procedimento per la preparazione di derivati dell' 11-dodecen-1-ile.
DE3784439D1 (de) Einrichtung zum sequenz-strangguss verschiedener stahlzusammensetzungen.
KR910010873U (ko) 폭 조절이 용이한 등산용 아이젠
IT1234211B (it) Procedimento di preparazione di derivati dell'1,4-benzodiazepina-4-one
IT8622736A0 (it) Antagonisti dell'aldosterone.
IT8748101A0 (it) Derivati 1,4-diidropiridinici quali agenti emoreologici
ITMI992617A0 (it) Procedimento per determinare il rapporto isotopico dell'azoto mediante analisi diretta
KR870016189U (ko) P.c콘크리트용 삼각형 강봉